Plenty of time. Bharat needs to present efficacy data from their existing trials in india and, i believe, numerous other developing countries. Not clear that getting vaccinated is a 'one and done' thing like small pox. I suspect it will be an annual event like the flu shot. Maybe some positive efficacy data from Bharat in the next couple of weeks will give $OCGN a price boost in anticipation of US distribution.
News 
Market Data 
Discover 
